Cas:628692-17-1 1-Benzothien-7-ylboronicacid manufacturer & supplier

Chemical Name:1-Benzothien-7-ylboronicacid

CAS.NO:628692-17-1

Synonyms:1-Benzothiophen-7-ylboronic acid;Boronic acid, B-benzo[b]thien-7-yl-;1-Benzothien-7-ylboronicacid

Molecular Formula:C₈H₇BO₂S

Molecular Weight:178.016

HS Code:2934999090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:390.2±34.0 °C at 760 mmHg

Density:1.4±0.1 g/cm3

Index of Refraction:1.669

PSA:68.70000

Exact Mass:178.025986

LogP:3.75

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1-Benzothiophen-7-ylboronic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-Benzothien-7-ylboronicacid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-Benzothiophen-7-ylboronic acid Use and application,Boronic acid, B-benzo[b]thien-7-yl- technical grade,usp/ep/jp grade.

Related News: It is estimated that the size of China’s CMO market has reached about USD 5 billion. With the implementation and further implementation of the MAH system (the core is to separate drug marketing authorization from drug production authorization) in China, it is expected to promote the outbreak of the domestic drug CMO industry. It will grow at a rate of 20% to 30%, of which patented APIs occupy a larger proportion. 1-Benzothien-7-ylboronicacid manufacturer Since inception in 2004, ICIG has acquired 15 businesses, all of which have origins in major global chemical or pharmaceutical corporations and are independently managed. 1-Benzothien-7-ylboronicacid supplier It is estimated that the size of China’s CMO market has reached about USD 5 billion. With the implementation and further implementation of the MAH system (the core is to separate drug marketing authorization from drug production authorization) in China, it is expected to promote the outbreak of the domestic drug CMO industry. It will grow at a rate of 20% to 30%, of which patented APIs occupy a larger proportion. 1-Benzothien-7-ylboronicacid vendor In recent years, there has been a relatively concentrated concentration of intermediate companies listed on the capital market. Most of the fund-raising projects are aimed at breaking through the bottleneck of production capacity to meet growing demand, and the entire industry has shown a vigorous development momentum. 1-Benzothien-7-ylboronicacid factory In the TOP50 list of API export companies in 2017, the geographical clustering of advantageous companies is still obvious. For example, Huahai and Pluo in Zhejiang, CSPC of Hebei, Xinhua Pharmaceutical and Xinfa Pharmaceutical of Shandong rank well. Rank.